Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Blend Labs
BLND
$482M
| $2.46M | ﹤0.01% |
962,609
+255,349
| +36% | +$385K |
|
1827
Bank of Marin Bancorp
BMRC
$478M
| $2.45M | ﹤0.01% |
111,368
-20,439
| -16% | -$392K |
|
1828
Greif Class B
GEF.B
$4.18B
| $2.45M | ﹤0.01% |
37,100
-6,910
| -16% | -$457K |
|
1829
Nexa Resources
NEXA
$1.79B
| $2.45M | ﹤0.01% |
342,900
+31,400
| +10% | +$185K |
|
1830
Amplify Energy
AMPY
$164M
| $2.44M | ﹤0.01% |
412,300
+41,400
| +11% | +$267K |
|
1831
Vanguard High Dividend Yield ETF
VYM
$82.6B
| $2.44M | ﹤0.01% |
21,900
+17,100
| +356% | +$1.8M |
|
1832
Olema Pharmaceuticals
OLMA
$1.03B
| $2.44M | ﹤0.01% |
173,611
-136,889
| -44% | -$1.84M |
|
1833
BioAtla
BCAB
$5.56M
| $2.43M | ﹤0.01% |
19,750
+7,246
| +58% | +$628K |
|
1834
WisdomTree Japan Hedged Equity Fund
DXJ
$7.2B
| $2.43M | ﹤0.01% |
27,600
+11,800
| +75% | +$1.04M |
|
|
OMCC
1835
DELISTED
Old Market Capital Corp
OMCC
| $2.43M | ﹤0.01% |
351,951
-8,025
| -2% | -$45.9K |
|
1836
Castle Biosciences
CSTL
$953M
| $2.43M | ﹤0.01% |
112,400
+5,600
| +5% | +$98.6K |
|
1837
FirstEnergy
FE
$27.9B
| $2.42M | ﹤0.01% |
+66,008
| New | +$2.39M |
|
1838
Addus HomeCare
ADUS
$2.12B
| $2.41M | ﹤0.01% |
26,000
-52,500
| -67% | -$4.56M |
|
1839
abrdn Physical Silver Shares ETF
SIVR
$4.13B
| $2.4M | ﹤0.01% |
+105,600
| New | +$2.35M |
|
1840
DigitalBridge
DBRG
$2.93B
| $2.4M | ﹤0.01% |
+137,022
| New | +$2.26M |
|
1841
AerSale
ASLE
$308M
| $2.4M | ﹤0.01% |
+189,100
| New | +$2.74M |
|
1842
C4 Therapeutics
CCCC
$399M
| $2.4M | ﹤0.01% |
424,700
+66,712
| +19% | +$152K |
|
1843
PC Connection
CNXN
$2.19B
| $2.39M | ﹤0.01% |
35,500
+10,600
| +43% | +$631K |
|
|
UCTT
1844
Ultra Clean Holdings
UCTT
$3.79B
| $2.39M | ﹤0.01% |
69,900
-48,400
| -41% | -$1.35M |
|
1845
iShares Russell Top 200 Growth ETF
IWY
$16.6B
| $2.38M | ﹤0.01% |
+13,600
| New | +$2.23M |
|
|
ICVX
1846
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $2.38M | ﹤0.01% |
+151,200
| New | +$1.46M |
|
|
PHLT
1847
DELISTED
Performant Healthcare Inc
PHLT
| $2.38M | ﹤0.01% |
762,363
-26,700
| -3% | -$70K |
|
1848
Washington Trust Bancorp
WASH
$761M
| $2.38M | ﹤0.01% |
73,500
-22,768
| -24% | -$620K |
|
1849
SolarEdge
SEDG
$2.97B
| $2.38M | ﹤0.01% |
25,400
-82,700
| -77% | -$7.53M |
|
1850
Atmus Filtration Technologies
ATMU
$4.5B
| $2.37M | ﹤0.01% |
100,900
-106,700
| -51% | -$2.29M |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.